Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016. [electronic resource]
Producer: 20130329Description: 314-20 p. digitalISSN:- 1527-7755
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Consolidation Chemotherapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Follicular -- drug therapy
- Neoplasm Staging
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Radioimmunotherapy -- methods
- Rituximab
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.